Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services Department was re-evaluating its $590 million contract to develop a bird flu ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.
HHS review of a vaccine contract sparks worries about preparedness for a potential bird flu pandemic
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and test vaccines against flu viruses that could ...
The Biden and Trump administrations have put billions into bird flu monitoring and prevention. But where is that money going?
Highly pathogenic avian influenza continues to devastate poultry flocks throughout the United States, as well as cause ...
Sky-high egg prices have drawn renewed attention to the bird flu outbreak, which has caused more than 166 million wild and ...
Under RFK Jr., HHS has canceled key vaccine meetings. Here's what that means for seasonal flu, bird flu, and childhood ...
The CDC has sequenced bird flu viruses from people in Nevada and Wyoming, and the Trump Administration has released a ...
Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback